Introduction. The discovery of mutations in the MEFV (for MEditerranean FeVer) locus has changed considerably the understanding of the most common auto-inflammatory disease Familial Mediterranean Fever (FMF). This gene encodes a protein called pyrin, expressed primarily on the innate immune system cells, including neutrophils, and cytokine-activated monocytes [1] . While it is known that pyrin interacts with five cellular proteins: PSTPIP1 [2] , 14-3-3 [3] , Caspase-1 [4] , ASC [5] , and Siva [6] , the exact function of pyrin in cell and the mechanism underlying the pathological effect of pyrin mutations are yet to be revealed. In transfected cells pyrin was observed to co-localize with actin in lamellar structures and in supranuclear ruffles, but not with stress fibers [7] . Since, actin plays a central role in biological motility as an essential constituent of cytoskeleton and a partner of intracellular signaling pathways associated with chemoattractant-receptor activation, here we investigated neutrophil F-actin, phagocytosis and macropinocytosis dynamics during neutrophil chemoattractant-dependent activation in FMF patients carrying homozygous or compound heterozygous mutations in the MEFV locus.
Materials and methods. Peripheral blood samples were obtained from 37 attack-free FMF patients, diag-nosed according to the Tel-Hasomer criteria [8] and 20 sex-and age-matched normal donors (ND). MEFV mutations in exon 10 were identified in all patients (18 patients were homozygous for the M694V mutation, 19 remaining patients were compound heterozygous for the M694V and one of the V726A, M680I, E148Q, R761H and F479L mutations). The quantitative flow cytometry determination of intracellular F-actin content was performed [9] . Whole blood samples were incubated with 20 ng/ml phorbol-12-myristate-13-acetate (PMA) or 10 -7 M N-formyl-Met-Leu-Phe (fMLP) or 1 µg/ml lipopolysaccharide (LPS) from Escherichia coli 026:B6 or 0.1-10 µg/ml colchicine (Col) for 1-10 min. Phagocytosis assay was performed using latex beads and dextran-FITC. Oscillation time-response curves were generated from calculated mean values ± SD data for F-actin content using the equation (1):
where Y represents a relative F-actin content, expressed as a mean channel number -MCN; B is a base line; A is an amplitude; F is a frequency and P is a phase shift of oscillation and t is time in min. A and F values were calculated using Graph Pad Prism v4.01 software and periods of oscillations (T) were calculated by equation (2) giving assumption that F-actin oscillates about a fixed point in a harmonic motion [10] :
Results and discussion. Unstimulated neutrophils F-actin content in FMF patients was significantly higher (P W < 0.01) than in ND (Fig. 1, A) . Pretreatment of whole blood with 10 µg/ml Col for 2 h increased neutrophil F-actin content in both FMF (P W < 0.007) and ND (P t < 0.0001). However, Col-pretreated neutrophils F-actin content in FMF patients was found to be significantly lower (P W ± 0.02) than in ND (Fig. 1, A) . The existence of several shifted maximums in F-actin dynamics of ND and FMF patient's activated neutrophils led us to test if this is due to different pattern of actin cytoskeleton polymerization and depolymerization regular cycles. fMLP-induced neutrophil F-actin oscillation showed differences in baseline, but not in amplitude and frequency of F-sactin oscillations (Fig. 1, B,  C) . The period of fMLP-induced neutrophil F-actin oscillation, for FMF patients was 4.08 ± 0.46 min and 4.09 ± 0.18 min for ND. As we expected, the period of F-actin oscillation in Col-pretreated neutrophil, activated by fMLP increased to 1.31 min in FMF patients (5.39 ± 0.13) and to 1.1 min in ND (5.19 ± 0.21). Thus, fMLP-stimulated and Col-pretreated neutrophils were characterized by different pattern of F-actin dynamics and delayed shift of maximums during FMF. We found that fMLP-, LPS-or PMA-stimulated neutrophil F-actin dynamics in FMF patients is characterized by oscillations with different amplitude and periods, whereas in ND's activated neutrophil F-actin dynamics has an undulating shape in the presence of fMLP only. Next, we analyzed how delayed F-actin oscillation period in FMF could contribute to altered F-actin dynamics during repeated fMLP action. We incubated ND's and FMF patient's whole blood neutrophils with fMLP for 10 min, then added equal amount of fMLP for 1-10 min and assayed the cellular F-actin content. We observed that repeated action of fMLP in ND (Fig.  2, A) induced significant reduction in both overall Factin content and cellular F-actin oscillation amplitude (1751 ± 166 in single dose fMLP treated cells versus 725 ± 120 MCN in double fMLP treated cells, P t = = 0.03). In contrast to ND, FMF patients' neutrophils failed to induce reduced F-actin dynamics during repeated action of fMLP (Fig. 2, B) . Indeed, neither Factin oscillation amplitude (1298 ± 104 in single dose fMLP treated cells versus 1442 ± 93 MCN in double fMLP treated cells) nor oscillation period (4.64 ± 0.11 versus 4.66 ± 0.09 min, respectively) were changed in FMF patient's neutrophils in the presence of single or double doses of fMLP.
The period of unstimulated neutrophil phagocytosis oscillation for FMF patients was 3.65 ± 0.03 min and 6.06 ± 0.12 min for ND (P t = 0.02) with enhanced amplitude (274.9 ± 37 MCN versus 68.7 ± 19 MCN in ND, P t = 0.04) and frequency of phagocytic uptake of latex beads. However, fMLP-stimulated neutrophil phagocytosis dynamics revealed oscillation behavior in FMF patients with two-fold increase in the period of latex beads phagocytic uptake (6.03 ± 0.05 min) and linear time-dependence in ND's. Unstimulated neutrophil macropinocytosis dynamics revealed oscillation behavior in ND's with the period of FITC-dextran uptake 7.21 ± 0.16 min, whereas the linear time-dependence was observed for FMF patients. The period of fMLPstimulated neutrophil macropinocytosis oscillation for FMF patients was found to be 4.78 ± 0.03 min and 6.4 ± 0.01 min for ND (P t = 0.04). Thus, the period of fMLP-stimulated neutrophil macropinocytosis oscillation in FMF patients was found to be much closer to the period of fMLP-stimulated F-actin oscillation (4.73 ± 0.13 min for F-actin and 4.78 ± 0.03 min for FITC-dextran uptake) compared with two-fold increase in the period of FITC-dextran uptake in ND (3.58 ± Neutrophils from ND (A) and FMF (B) in 100 µl of whole blood were incubated for 10 min with (+) or without (-) fMLP and then equal concentration of these chemoattractant added to blood samples and incubated for additional 1-10 min. The reaction is stopped at the appropriate time and the intracellular F-actin content is measured as described in Materials and methods. Oscillation curves (upper boxed graphs) were generated using the equations (1) and (2) . All data represent means ± SD (error bars) and are significantly different at P t or P p £ 0.05 (*), comparing with single and double fMLP-treated neutrophils ± 0.17 min for F-actin and 6.49 ± 0.01 min for FITCdextran uptake).
There are a number of unexpected findings described in this study. The first unexpected finding is the increasing of overall F-actin content in unstimulated neutrophils in FMF patients. Second, we found that repeated action of fMLP in ND induced significant reduction of both overall F-actin content and cellular Factin oscillation amplitude, which paralleled with double increasing of neutrophil F-actin oscillation period. The resolution of inflammation can now be regarded as an integral component of the neutrophil activation negative regulation programs [11] . The best known example is the phenomenon, known as neutrophil chemoattractant receptors desensitization. When neutrophils encounter increasing concentration of chemoattractant, they gradually become nonresponsive to further stimulation by the same agent. In contrast to ND, FMF patients' neutrophils failed to induce reduced F-actin dynamics during repeated action of fMLP, suggesting that neutrophils from FMF patients fail to induce chemoattractant receptor desensitization. In conclusion we suggested that mutant MEFV-encoded pyrin may contribute to the decreasing of plasticity of cellular cytoskeleton and neutrophils failed to induce reduced F-actin or phagocytosis dynamics during repeated action of different chemoattractant or particles.
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Му тації в гені MEFV спри чи ня ють по ру шен ня у вмісті F-ак ти ну не й трофілів та ди наміці фа го ци то зу Ре зю ме 
Мета. Вив чен ня ди наміки внутрішньоклітин но го вмісту F-ак ти -ну, фа го ци то зу і мак ропіно ци то зу не й трофілів у хво рих на сімей-ну се ред зем но мо рську ли хо ман ку (ССЛ) для виз на чен ня мо ле ку

